Doctor profile · Federal record

Dr. Darik Taniguchi, M.D.

Gastroenterology Physician (CMS: Gastroenterology) · Seattle, WA

  • NPI 1750359105
  • Accepts Medicare
  • 38 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
11027 Meridian Ave N, Suite 100
Seattle, WA 981331705
(206) 365-4492
fax (206) 368-3456
Mailing address
Po Box 34888
Seattle, WA 981241888

Credentials & registration

NPPES · NUCC
NPI registered
March 2006 — 20 yrs on file
Profile last updated
November 20, 2014
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State license (1)
Washington #MD00027759
Medicaid
WA #1018075

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750359105. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,741
Distinct HCPCS
10
Medicare allowed
$140,751
HCPCS Description Services Patients Avg allowed
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,080 11 $33
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 160 159 $267
99214 Established patient office or other outpatient visit, 30-39 minutes 147 117 $135
99213 Established patient office or other outpatient visit, 20-29 minutes 98 89 $96
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 69 68 $95
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 40 40 $186
99203 New patient office or other outpatient visit, 30-44 minutes 30 30 $120
45380 Biopsy of large bowel using a flexible endoscope 29 29 $131
96413 Administration of chemotherapy into vein, 1 hour or less 24 12 $148
99202 New patient office or other outpatient visit, 15-29 minutes 18 18 $72

In context: peer comparison

Among 44 peers in this city , average services per provider: 39. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,617
Transactions
75
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 19 $754.84
Phathom Pharmaceuticals, Inc. 5 $286.24
Takeda Pharmaceuticals U.S.A., Inc. 8 $220.15
Janssen Biotech, Inc. 4 $199.21
Madrigal Pharmaceuticals 3 $178.65
Lilly USA, LLC 3 $178.45
AIMMUNE THERAPEUTICS, INC. 7 $167.45
PFIZER INC. 7 $140.25
GENZYME CORPORATION 3 $96.62
Celgene Corporation 5 $92.16
Salix Pharmaceuticals, a division of Bausch Health US, LLC 3 $68.87
Celltrion USA Inc. 2 $51.41
Merck Sharp & Dohme LLC 2 $46.73
Intercept Pharmaceuticals, Inc. 2 $41.32
Braintree Laboratories, Inc. 2 $39.76

By nature of payment

Food and Beverage
$2,566
Education
$51

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
951
Patients
369
Total drug cost
$171,299
Drug Type Claims Patients Total cost
Omeprazole Generic 210 63 $3,634
Pantoprazole Sodium Generic 162 55 $3,824
Famotidine Generic 133 49 $3,086
Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates) Brand 89 89 $6,801
Dicyclomine Hcl Generic 50 27 $1,704
Loperamide (Loperamide Hcl) Brand 46 12 $1,752
Clenpiq (Sod Picosulf/Mag Ox/Citric Ac) Brand 42 42 $7,296
Creon (Lipase/Protease/Amylase) Brand 38 0 $59,056
Sucralfate Generic 38 11 $7,469
Budesonide Dr (Budesonide) Brand 33 0 $7,348

Frequently asked questions

Auto-generated from federal data
What is Dr. Darik Taniguchi's medical specialty?
Dr. Darik Taniguchi practices Gastroenterology Physician in Seattle, WA.
Where does Dr. Darik Taniguchi practice?
Dr. Darik Taniguchi practices at 11027 Meridian Ave N, Seattle, WA 981331705. Office phone: 2063654492.
What is Dr. Darik Taniguchi's NPI?
Dr. Darik Taniguchi's National Provider Identifier (NPI) is 1750359105, issued by NPPES.
Does Dr. Darik Taniguchi accept Medicare assignment?
Yes. Dr. Darik Taniguchi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Darik Taniguchi commonly perform?
Top Medicare-reported procedures in 2023: Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Removal of polyps or growths of large bowel using an endoscope with mechanical snare (HCPCS 45385); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.